Featured Article

Important Role of Health Surveillance Systems in Community‐Based Colorectal Cancer Screening
Ann Chao, Sudha Sivaram
The Oncologist 2018; first published on July 26, 2018; doi:10.1634/theoncologist.2018-0178


The Implementation and First‐Round Results of a Community‐Based Colorectal Cancer Screening Program in Shanghai, China
Yangming Gong, Peng Peng, Pingping Bao, Weijian Zhong, Yan Shi, Kai Gu, Ying Zheng, Chunxiao Wu, Sanjun Cai, Ye Xu, Jun Sheng and Fan Wu
The Oncologist 2018; first published on March 14, 2018; doi: 10.1634/theoncologist.2017-0451


Recent Translated Articles from The Oncologist


Volume 23: Number 11, November 2018


Clinical Trial Results

Ganetespib 联合阿柏西普治疗晚期肿瘤和肉瘤患者的Ⅰ期研究
A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas
Robert Meehan, Shivaani Kummar, Khanh Do, Geraldine O'Sullivan Coyne, Lamin Juwara, Jennifer Zlott, Larry Rubinstein, James H. Doroshow, Alice P. Chen
The Oncologist 2018; 23:1269-e125; first published on May 31, 2018; doi:10.1634/theoncologist.2018-0203

单剂瑞格非尼对之前接受过 FOLFOXIRI + 贝伐珠单抗治疗且具有任何 RAS 或 BRAF 基因突变的转移性结直肠癌患者的疗效 (PREVIUM 试验)
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)
Pilar García‐Alfonso, Manuel Benavides, Esther Falcó, Andrés Muñoz, Auxiliadora Gómez, Javier Sastre, Fernando Rivera, Clara Montagut, Mercedes Salgado, Amelia López‐Ladrón, Rafael López, Inmaculada Ruiz de Mena, Gema Durán, Enrique Aranda, on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD)
The Oncologist 2018; 23:1271-e128; first published on August 17, 2018; doi:10.1634/theoncologist.2018-0316


Breast Cancer

淀粉样前体蛋白与非管腔型乳腺癌的侵袭性行为相关
Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast Cancers
Julia Y.S. Tsang, Michelle A. Lee, Yun‐Bi Ni, Siu‐Ki Chan, Sai‐Yin Cheung, Wai‐Wa Chan, Kwok‐Fai Lau, Gary M.K. Tse
The Oncologist 2018; 23:1273-1281; first published on August 14, 2018; doi:10.1634/theoncologist.2018-0012

仅骨转移的转移性乳腺癌患者的预后因子
Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases
Amanda Parkes, Carla L. Warneke, Katherine Clifton, Aydah Al‐Awadhi, Oluchi Oke, Roberto Carmagnani Pestana, Omar Alhalabi, Jennifer K. Litton, Gabriel N. Hortobagy
The Oncologist 2018; 23:1282-1288; first published on August 17, 2018; doi:10.1634/theoncologist.2018-0085

基于 mTOR 的系统治疗方案对晚期、化生和非化生三阴性乳腺癌的效果比较
Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer
Reva K. Basho, Clinton Yam, Michael Gilcrease, Rashmi K. Murthy, Thorunn Helgason, Daniel D. Karp, Funda Meric‐Bernstam, Kenneth R. Hess, Vicente Valero, Constance Albarracin, Jennifer K. Litton, Mariana Chavez‐MacGregor, David Hong, Razelle Kurzrock, Gabriel N. Hortobagyi, Filip Janku, Stacy L. Moulder
The Oncologist 2018; 23:1300-1309; first published on August 23, 2018; doi:10.1634/theoncologist.2017-0498


Gastrointestinal Cancer

循环肿瘤DNA 分析应用于转移性结直肠癌患者的临床效用
Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
Yoshiaki Nakamura, Takayuki Yoshino
The Oncologist 2018; 23:1310-1318; first published on April 26, 2018; doi:10.1634/theoncologist.2017-0621

食管鳞状细胞癌、食管腺癌及胃腺癌的比较分子分析
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma
Mohamed E. Salem, Alberto Puccini, Joanne Xiu, Derek Raghavan, Heinz‐Josef Lenz, W. Michael Korn, Anthony F. Shields, Philip A. Philip, John L. Marshall, Richard M. Goldberg
The Oncologist 2018; 23:1319-1327; first published on June 4, 2018; doi:10.1634/theoncologist.2018-0143


Hematologic Malignancies

干扰素-α 可有效治疗异基因造血干细胞移植后 t(8;21) 急性髓性白血病患者的微小残留病:前瞻性登记研究结果
Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study
Xiao‐Dong Mo, Yu Wang, Xiao‐Hui Zhang, Lan‐Ping Xu, Chen‐Hua Yan, Huan Chen, Yu‐Hong Chen, Ya‐Zhen Qin, Kai‐Yan Liu, Xiao‐Jun Huang
The Oncologist 2018; 23:1349-1357; first published on August 3, 2018; doi:10.1634/theoncologist.2017-0692


Lung Cancer

纳武单抗治疗晚期非小细胞肺癌产生的免疫相关不良事件与临床受益的关系
Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab
Yukihiro Toi, Shunichi Sugawara, Yosuke Kawashima, Tomoiki Aiba, Sachiko Kawana, Ryohei Saito, Kyoji Tsurumi, Kana Suzuki, Hisashi Shimizu, Jun Sugisaka, Hirotaka Ono, Yutaka Domeki, Keisuke Terayama, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yoshihiro Honda
The Oncologist 2018; 23:1358-1365; first published on June 22, 2018; doi:10.1634/theoncologist.2017-0384